New

Unexpected Effect of Substance Use Disorders on Recovery From Bipolar Depression

Contrary to the investigators’ hypotheses, it was found that current co-occurring substance use disorders could significantly predict the likelihood of recovery from an episode of bipolar depression, as well as the time to recovery.

New

Republican Opposition to Obamacare: What’s Done, What’s to Come

Republicans who have fought against the Affordable Care Act (ACA) for years are at a crossroads after their opposition largely failed.

New

Early Childhood Out-of-Home Placement Associated With Adverse Outcomes in Adulthood

These results suggest a significant need for psychiatric resources for children placed in foster care or other out-of-home circumstances.

New

Integrating Treatments for Opioid Use Disorder and Infectious Diseases

All healthcare providers have a role in combating the opioid use disorder epidemic and its infectious disease consequences.

New

Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC

The prevalence of opioid use disorder rose in women delivering at hospitals across 28 US states and the District of Columbia between 1999 and 2014, with quadrupling at the national level during this period.

New

Light Therapy Effective for Older Adults with Nonseasonal Depression

Rapid onset of antidepressant effects, mild and infrequent adverse effects, and cost-effectiveness position light therapy as an alternative to pharmacologic treatments for depression.

New

Appetitive Symptoms, Fluoxetine, and Light Therapy: Predicting Treatment Response for Nonseasonal Major Depression

Researchers examined whether more severe appetitive symptoms predicted a positive response to light therapy.

New

Bipolar Disorder Patients Benefit From Coping Strategies for Amplified Emotionality

The findings confirmed amplified emotionality associated with bipolar disorder and demonstrated fluctuations in different components of coping flexibility and mood states across time.

New

Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives

Research has been insufficient to elucidate the prevalence, course, and clinical correlates of rapid cycling in bipolar disorder.

New

ADHD Medications Compared for Efficacy, Tolerability in Children and Adults

The 7 treatments included in the study were amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil.

New

Short Form of Geriatric Depression Scale May Be Useful Assessment Tool Across Adult Lifespan

The GDS-15 uses short sentences and a yes/no format, which is easier for patients who are struggling with depression, fatigue, or cognitive impairment to tolerate.

New

First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide

Researchers found a suicide attempt rate of 12.0% in first-episode, drug-naïve inpatients.

New

Posttraumatic Stress Disorder Associated With Reduced Brain Volume

Investigators compare brain changes in PTSD because they could be associated with the comorbid major depressive disorder rather than the diagnosis of PTSD.

New

Disease Specific Variables Effecting Quality of Life in First-Episode Psychosis

Quality of life has emerged as an important factor for research because it may be valuable to measure treatment outcomes.

New

Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome

This finding suggests that clinicians should monitor anxiety among individuals with testosterone deficiency and XXY.

New

Pharmacologic Treatment of First-Episode Psychosis: Advances in Research

The NAVIGATE program shows great promise toward optimizing pharmacologic management of psychosis.

New

Does Bipolar I Disorder Effect the Course of Conduct/Antisocial Personality Disorders in Adolescents?

Adolescents with bipolar I disorder whose symptoms are in remission are significantly less likely to experience conduct disorder or antisocial personality disorder.